Bim may be a poor prognostic biomarker in breast cancer patients especially in those with luminal A tumors-Reference-Cited by-同舟云学术

Bim may be a poor prognostic biomarker in breast cancer patients especially in those with luminal A tumors

Published:2017-07-04 Issue:4 Volume:19 Page:411-418
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Maimaiti Yusufu¹¹,Dong Lingling²¹,Aili Aikebaier¹,Maimaitiaili Maimaitiaili¹,Huang Tao²,Abudureyimu Kelimu¹

Affiliation:

1. Department of General Surgery, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China

2. Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference32 articles.

1. The changing role of pathology in breast cancer diagnosis and treatment;Leong;Pathobiology,2011

2. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011;Goldhirsch;Ann Oncol,2011

3. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer;Cheang;J Natl Cancer Inst,2009

4. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, The Lancet 365 (2005), 1687–1717.

5. Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status;Dowsett;Ann Oncol,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primed for death: prognostic role of BH3--only proteins in breast cancer therapy: a systematic and meta-analysis review;Translational Medicine Communications;2024-08-22

2. BAY-885, a mitogen-activated protein kinase kinase 5 inhibitor, induces apoptosis by regulating the endoplasmic reticulum stress/Mcl-1/Bim pathway in breast cancer cells;Bioengineered;2022-05-02

lncRNA MT1JP Suppresses Biological Activities of Breast Cancer Cells in vitro and in vivo by Regulating the miRNA-214/RUNX3 Axis

;OncoTargets and Therapy;2020-06

4. Long-Chain Non-Coding RNA (lncRNA) MT1JP Suppresses Biological Activities of Lung Cancer by Regulating miRNA-423-3p/Bim Axis;Medical Science Monitor;2019-07-10

5. Inactivation of SAG or ROC1 E3 Ligase Inhibits Growth and Survival of Renal Cell Carcinoma Cells: Effect of BIM;Translational Oncology;2019-06